Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Xiaolei Lai"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Traditional Chinese medicine injections with invigorating blood circulation (TCMI-IBCs), which have been used as antithrombosis therapies, are widely employed by Chinese clinicians as adjuvant therapy for acute myocardial infarction (AMI)
Externí odkaz:
https://doaj.org/article/ecaa954d61ce46bd97f9e1317832ae15
Autor:
Pengyu Liu, Juju Shang, Zhi Qi, Shenglei Qiu, Xiaolei Lai, Lixiao Shi, Zhenmin Zhang, Mingxuan Li, Linjing Yang
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
BackgroundsCurrent observational investigations hint at a potential linkage between ankylosing spondylitis and cardiovascular wellness. However, the nature of this causality remains to be elucidated. Consequently, this study is designed to evaluate t
Externí odkaz:
https://doaj.org/article/2f005dd41fdb4a94939df373e72163f6
Publikováno v:
Heliyon, Vol 9, Iss 5, Pp e16012- (2023)
Objective: To systematically evaluate the effectiveness of Traditional Chinese Medicine Cutaneous Regions Therapy (TCMCRT) as an adjunctive treatment for chronic heart failure. Methods: China National Knowledge Infrastructure (CNKI), Wanfang database
Externí odkaz:
https://doaj.org/article/478a80a649564c738593ccb15363e8a8
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background:Salvia miltiorrhiza Bunge. [Lamiaceae, danshen] injection classes (SMIC) is widely used in the treatment of unstable angina (UA). However, it is uncertain which SMIC is more effective in terms of UA efficacy. The purpose of this Network Me
Externí odkaz:
https://doaj.org/article/a21e4af0c8f848828781f303b6a45943
Publikováno v:
Evidence-Based Complementary and Alternative Medicine. 2022:1-23
Background. Chinese medicine injections (CMIs) are widely used in the prevention and treatment of cardiotoxicity caused by anthracycline chemotherapeutic drugs. However, it is uncertain that CMIs are more effective in combating the cardiotoxicity of
Autor:
Juju Shang, Shenglei Qiu, Yingjie Zhou, Sina Liu, Zi Wang, Xiaolei Lai, Hongxu Liu, Mingxue Zhou, Zhenmin Zhang, Pengyu Liu, Fangfang Zhang, Xianghui Meng
Publikováno v:
Medicine. 101(47)
Acute myocardial infarction (AMI) is a common cause of death worldwide and heart failure (HF) is the main complication. Although the increase in percutaneous coronary intervention and drug treatment can reduce in-hospital mortality after AMI, the inc
Autor:
Xin Hu, Juju Shang, Hongxu Liu, Wen-Long Xing, Xiaolei Lai, Jing-Feng Tian, Xiang Li, Qi Zhou
Publikováno v:
Chinese Journal of Integrative Medicine. 27:323-329
To assess the trends in characteristics, treatments, and outcomes of acute myocardial infarction (AMI) patients in tertiary Chinese medicine (CM) hospitals in China between 2006 and 2013. This retrospective study was based on two nationwide epidemiol
Autor:
Xiaolei, Lai, Ying, Zhang, Mengjie, Li, Juju, Shang, Weihong, Liu, Mingxue, Zhou, Hongxu, Liu
Publikováno v:
Acta Cardiol Sin
BACKGROUND: Moderate autophagy plays a positive role in the prevention of atherosclerosis. Aberrant promoter methylation of autophagic genes can affect autophagy. Shen-Yuan-Dan Capsule (SYDC), a traditional Chinese medicine, can prevent atheroscleros
Autor:
Wen-Long Xing, Juju Shang, Yu-Tong Fei, Xue-yan Sun, Hongxu Liu, Xiang Li, Qi Zhou, Si-Han Jia, Xiaolei Lai
Background: Peri-procedural myocardial injury (PMI) during percutaneous coronary intervention (PCI) will result in an unfavorable clinical prognosis in patients, thus urgently necessitating effective drug treatment measures. Shen-Yuan-Dan (SYD) capsu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7987f035515da68ac78e8f5eb64f26a1
https://europepmc.org/articles/PMC6465441/
https://europepmc.org/articles/PMC6465441/